About US
Contact us
-
Japan OKs warfarin alternative Eliquis from BMS, PfizerBristol-Myers Squibb ($BMY) and Pfizer ($PFE), which have yet to get their blood thinner Eliquis approved in the U.S., have gotten a third regulatory nod elsewhere. Japan approved the warfarin alte2012/12/27
-
Amgen licenses exclusive right to use ImmunoGen TAP technologyGlobal biotech company Amgen has licensed the exclusive right to use ImmunoGen's Targeted Antibody Payload (TAP) technology to develop anti-cancer therapies. It has already used the technology to deve2012/12/27
-
Sanofi animal health deal puts it in IndiaSanofi ($SNY) has found something to like about its prospects in India besides the country's huge population of potential drug consumers. The country also has a lot of livestock and that need drugs, t2012/12/21
-
GSK reaches $150M deal in Flonase antitrust caseGlaxoSmithKline ($GSK) and a group of drug wholesalers have come to terms in a lawsuit over generic Flonase. The drugmaker agreed to pay $150 million to the companies--including Meijer, AmerisourceBer2012/12/21
-
Sartorius Stedim Biotech Expands PAT Software Portolio for Optimization of Biopharmaceutical Development and Manufacturing ProcessesSartorius Stedim Biotech (SSB), a leading international pharmaceutical and biotech supplier, has entered into a global sales partnership with Umetrics AB, a Swedish software manufacturer. Umetrics is2012/12/20
-
Judge blocks Endo's effort to block generic pain medsEndo Health Solutions' ($ENDO) attempt to outmaneuver generic competition by kicking dirt all over its own product has come up short. A federal judge in Washington declined to force the FDA to declar2012/12/20
-
UPDATE: Amgen pleads guilty in $762M Aranesp settlementAmgen's ($AMGN) long-brewing settlement with the U.S. Justice Department is close at hand. The drugmaker pleaded guilty today to a misdemeanor misbranding charge for mismarketing its anemia drug Arane2012/12/19
-
Valeant cuts 200 Medicis jobs as $2.6B deal closesValeant Pharmaceuticals ($VRX) isn't pussyfooting around Medicis. As the built-by-acquisition Canadian company wrapped up its deal for Medicis last week, some 200 employees were told to pack their ba2012/12/19
-
WIN Consortium announces collaboration with PfizerPfizer has become the first pharmaceutical partner of the Worldwide Innovative Network (WIN) Consortium - a global network of academic, industry and patient advocacy organisations working to advance2012/12/18
-
Novartis orphan drug Signifor gets another approvalDrugmakers are seeing more market potential in orphan drugs, and drug regulators are rewarding them with approvals. The FDA has for the second time this year approved an orphan drug for the rare Cush2012/12/18